series-c-plus
Stage
2018
Founded
1
Investors
About
BioVentrix is a medical device company developing and commercializing less invasive therapies for patients with heart failure caused by ischemic cardiomyopathy, using its Revivent TC™ System.
Explore BioVentrix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.